• NUAK1 Inhibition Lowers Pathogenic Tau Ser356 in Alzheimer’s

  2026-05-30

  Taylor et al. (2023) demonstrate that phosphorylation of tau at Ser356—a process mediated by NUAK1—is closely associated with Alzheimer’s disease progression and neurofibrillary tangle pathology. Using the NUAK1/2 inhibitor WZ4003, the study reveals that targeted NUAK inhibition reduces pathogenic p-tau Ser356 in both mouse and human brain slice cultures, offering mechanistic insight for future therapeutic strategies in neurodegenerative disease research.

• Pravastatin Sodium in Translational Research: Beyond Cholest

  2026-05-29

  Explore how Pravastatin sodium, a potent HMG-CoA reductase inhibitor, advances translational biomedical research by enabling precise cholesterol biosynthesis inhibition and uncovering new applications in metabolic and tumor biology. This article provides a mechanistic, protocol-driven analysis you will not find elsewhere.

• Niclosamide: Advanced STAT3 Inhibition in Leukemia Models

  2026-05-29

  Explore how Niclosamide, a small-molecule STAT3 inhibitor, enables advanced mechanistic research in acute myelogenous leukemia models. This article uniquely connects its molecular action to comparative assay design and plant-derived alternatives, offering critical insights for cancer researchers.

• Panobinostat Disrupts Epigenetic Maintenance in MLL-ALL Mode

  2026-05-28

  This study demonstrates that panobinostat, a broad-spectrum histone deacetylase inhibitor, exerts potent anti-leukaemic effects in vivo against MLL-rearranged acute lymphoblastic leukaemia (ALL) by disrupting the RNF20/RNF40/WAC-H2B ubiquitination axis. The findings highlight a novel mechanistic vulnerability in MLL-ALL and provide a rational basis for future epigenetic therapy development.

• Cyclo (-RGDfC) in High-Throughput Tumor Targeting Assays

  2026-05-28

  Cyclo (-RGDfC) empowers advanced cancer and angiogenesis research through precise, reproducible αvβ3 integrin targeting. Its cyclic structure and high affinity enable robust results in high-throughput hydrogel and cell adhesion workflows, especially when paired with modern digital light printing platforms.

• HyperFusion™: High-Fidelity DNA Polymerase for Precise PCR

  2026-05-27

  HyperFusion™ high-fidelity DNA polymerase offers over 50-fold greater fidelity than Taq polymerase and robust amplification of GC-rich or long templates. This proofreading DNA polymerase is engineered for accuracy, speed, and inhibitor tolerance, making it ideal for applications such as cloning and high-throughput sequencing. APExBIO’s enzyme sets a new benchmark for reproducible, reliable PCR workflows.

• Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301): P

  2026-05-27

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) offer efficient and specific capture of biotinylated molecules, streamlining purification and immunoprecipitation workflows in molecular biology. They are optimal for applications requiring high-affinity binding and low nonspecific background, but are not suited for use with non-biotinylated targets or in workflows sensitive to bovine serum albumin or sodium azide.

• Laminin (925-933): Mechanistic Precision in Translational Re

  2026-05-26

  Laminin (925-933), a synthetic peptide from the laminin B1 chain, is redefining how translational researchers approach cell adhesion and migration studies. By emulating a critical extracellular matrix domain, this tool offers unmatched specificity for cell adhesion and chemotaxis assays—enabling precise modeling of metastasis and tissue remodeling. This article synthesizes mechanistic insights, evidence-based guidance, and strategic foresight, serving as a blueprint for leveraging Laminin (925-933) in advanced translational workflows.

• Novel Antifungal Strategies Against Candida auris: Systemati

  2026-05-26

  This systematic review synthesizes the latest antifungal pipeline developments targeting multidrug-resistant Candida auris. Emphasizing investigational agents with novel mechanisms, the study highlights the urgent need for new therapies and provides comparative data on efficacy and selectivity relevant for translational research.

• NLRP3 Inflammasome and Coagulation in Endotoxemic Mice: New

  2026-05-25

  This study delineates the distinct contributions of TLR4, caspase-11, and the NLRP3 inflammasome to the release of tissue factor-positive extracellular vesicles (EVs) and coagulation activation in a mouse model of endotoxemia. The findings clarify that while TLR4 is the primary driver of coagulation, caspase-11 and NLRP3 have more limited, time-dependent roles, refining the mechanistic understanding of coagulation in sepsis and informing targeted research strategies.

• Selective Nanomolar IRAP Inhibitors via α-Hydroxy-β-Amino Be

  2026-05-25

  This study presents a highly selective, nanomolar inhibitor of insulin-regulated aminopeptidase (IRAP) based on a synthetic α-hydroxy-β-amino acid scaffold derived from bestatin. Through regio- and stereoselective functionalization and structural analysis, the work advances both inhibitor design and mechanistic understanding, providing new chemical tools for probing M1 zinc aminopeptidases.

• 10074-G5: Advanced c-Myc Inhibitor Workflows in Cancer Resea

  2026-05-24

  10074-G5 enables precise disruption of c-Myc/Max dimerization, empowering next-generation cancer research assays. This guide delivers protocol-driven insights, troubleshooting strategies, and direct applications for apoptosis, cell cycle arrest, and tumor regression studies.

• MAPK10 Regulates NSCLC Metastasis via KRT16 Ubiquitination

  2026-05-23

  This study reveals that mitogen-activated protein kinase 10 (MAPK10) suppresses non-small cell lung cancer (NSCLC) metastasis by promoting phosphorylation-dependent ubiquitination and degradation of keratin 16 (KRT16). These findings define a novel MAPK10/KRT16/RNF213 axis with significant implications for biomarker discovery and targeted intervention in NSCLC.

• Indazole/Indole-Based Glucagon Receptor Antagonists: Synthes

  2026-05-22

  This study introduces a novel series of indazole- and indole-based glucagon receptor antagonists as promising leads for type 2 diabetes therapy. By detailing the synthetic strategies and structure–activity relationships, the work advances our understanding of targeted amide bond formation in complex small molecule development.

• KR-12 Peptide Mitigates Colitis via Anti-Inflammatory and An

  2026-05-22

  The referenced study demonstrates that the human antimicrobial peptide fragment KR-12 significantly reduces inflammation and bacterial burden in multiple mouse models of colitis. These findings highlight KR-12's potential as a novel therapeutic candidate for inflammatory bowel diseases, with mechanistic evidence supporting both its immunomodulatory and direct antimicrobial roles.

16039 records 1/1070 page Next 12345 下5页 Last page